Sign in
Taking people in United StatesNo phase

Brain activity training with scan feedback for teenagers with Tourette syndrome

Tests scan-guided brain training in teenagers with Tourette syndrome or chronic tics.

Key facts

Who runs it
Yale University
Where
New Haven, United StatesSee the site
Trial code
Registry title
Neurofeedback From the Supplementary Motor Area for Tourette Syndrome
Status
Recruiting
People taking part
64 people, planned
Started
1 Nov 2022
Expected to end
20 Jan 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Neurofeedback from the SMA
  • Neurofeedback from control region
Record updated
9 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for young people aged 10 to 16 with Tourette Syndrome or chronic tic disorder. They get brain-scan (fMRI) neurofeedback from one of two brain areas.

Age
10 to 16 years
Sex
Boys and girls
Disease stage
A current diagnosis of Tourette Syndrome or chronic tic disorder. Active tics that can be done without moving the head. A YGTSS tic score of at least 13 for Tourette Syndrome, or at least 12 for chronic tic disorder.
Earlier treatment
Medicines must be stable, with no changes planned during the study. Psychotherapy started less than 8 weeks ago is not allowed. Ongoing psychotherapy started at least 8 weeks before can continue.

Main reasons for not taking part

  • IQ below 80
  • Autism spectrum disorder, bipolar or psychotic disorder, or current suicidal thoughts
  • Serious illness such as heart disease, high blood pressure, liver or kidney failure, lung disease or seizures
  • Metal medical implants or braces, pregnancy, body weight of 250 lbs (113 kg) or more, or fear of closed spaces
  • Living more than 2 hours from Yale Medical Center, or child and parents cannot speak and understand English

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Boys and girls, 10 to 16 years of age
  • A current diagnosis of Tourette Syndrome (TS) or chronic tic disorder (CTD), with active tics that can be executed without head movement, and a YGTSS score of at least 13 (for TS participants) or at least 12 (for CTD participants)
  • Currently stable medication treatment and no planned changes in medication for the duration of the study
  • Family residence within 2 hours of Yale Medical Center with ability and willingness to attend assessment and fMRI visits
  • Children and their parents are expected to be able to speak and understand spoken English in order to participate in a clinical assessment of TS and related psychopathology
  • Subjects will be free of: 1) metal medical implants or braces, 2) pregnancy, and will have 3) a body weight of less than 250 lbs. and 4) no claustrophobia

Who cannot take part

  • Recently initiated psychotherapy. Participation in the study will not be allowed within 8 weeks of the initiation of psychotherapy. Ongoing, concurrent psychotherapy (that was initiated at least 8 weeks previously) for the child will be allowed, but parents will be asked not to initiate any new psychotherapy for the child during the study
  • Current diagnosis of autism spectrum disorder, bipolar or psychotic disorder or current suicidality
  • Significant medical condition such as heart disease, hypertension, liver or renal failure, pulmonary disease, seizure disorder
  • Subjects may also be excluded after the first MR scan if we are unable to localize the two regions in their brain that are used as targets for the active and control neurofeedback conditions
  • Intelligence quotient below 80

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 10 and 16 years old?

Where in United States

  • Yale University School Of MedicineNew Haven, United StatesContact: Michelle Hampson, PhD (principal investigator)Taking people

About the trial

What the trial wants to find out

This is a clinical trial where adolescents aged 10-16 years old with Tourette Syndrome (or chronic tic disorder) are randomized to receive either real-time functional magnetic resonance imaging (fMRI) neurofeedback targeting the supplementary motor area (for the experimental intervention) or real-time fMRI neurofeedback (NF) from a control region (for the control intervention).

The 2 groups in the trial

  • Neurofeedback from the SMATreatment being tested
  • Neurofeedback from control regionExisting treatment, for comparison

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Neurofeedback From the Supplementary Motor Area for Tourette Syndrome
Plain-language title
Brain activity training with scan feedback for teenagers with Tourette syndromeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT05558566, who can take part
Record updated
9 June 2026